Search Results
Aug 12, 2026, 07:00 ET Insurify Names Former KAYAK AI Leader Jake Bouvrie as Its First Chief AI Officer
firsthand. Jake combines deep machine learning research with operating experience across insurance, a global consumer marketplace, and enterprise R&D. He's the right leader to help us translate the opportunities of AI into measurable value.""Over the past two decades, AI has moved from research
More news about: INSURIFY, Inc.
Aug 12, 2026, 07:00 ET Leap Therapeutics Announces Publication of DeFianCe Study Results in Clinical Cancer Research
were concordant across two orthogonal platforms — an aptamer-based SomaScan assay and an antibody-based Meso Scale Discovery (MSD) assay (Spearman r=0.77).Tumoral DKK1 mRNA expression was low in most tissue samples, reinforcing that plasma — not tissue — reflects the systemic DKK1 burden relevant
More news about: Cypherpunk Technologies Inc.
Aug 12, 2026, 06:50 ET Protalix BioTherapeutics Reports Second Quarter 2026 Financial and Business Results
the same periods in 2025. Both periods reflect a $2.1 million grant receivable recorded under the new R&D law as a reduction of R&D expenses. The Company expects to continue to incur R&D expenses as the RELEASE study progresses and additional preclinical and clinical programs advance.Selling,
More news about: Protalix BioTherapeutics, Inc.
Aug 12, 2026, 06:30 ET Bio-Techne Declares Dividend
provides high–quality reagents, analytical instruments, and precision diagnostics. Its portfolio is organized into three customer–focused brands: R&D Systems™, Bio–Techne Spatial™, and Bio–Techne Diagnostics™, reflecting the scientific journey from discovery to translational research to clinical
More news about: Bio-Techne Corporation
Aug 12, 2026, 06:30 ET Bio-Techne Releases Fourth Quarter Fiscal 2026 Results
provides high‑quality reagents, analytical instruments, and precision diagnostics. Its portfolio is organized into three customer‑focused brands: R&D Systems™, Bio‑Techne Spatial™, and Bio‑Techne Diagnostics™, reflecting the scientific journey from discovery to translational research to clinical
More news about: Bio-Techne Corporation
Aug 12, 2026, 06:06 ET CGTN Spanish: Innovation in Shenzhen: Connecting China with the Asia-Pacific Region
previously could not easily access industrial AI to benefit from it. This is undoubtedly the future trend," said Shi Xiaoliang, Director of Product R&D at SmartMore.At APEC China 2026, with innovation among the region's priorities, Shenzhen will demonstrate how its technology and industrial
More news about: CGTN Spanish
Aug 12, 2026, 06:00 ET Eloxx Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
six months ended June 30, 2026, net loss was $8.3 million, compared to $3.6 million for the same period in 2025.Research and development (R&D) expenses were $2.8 million for the three months ended June 30, 2026, compared to $0.9 million for the same period in 2025. The increase was primarily
More news about: Eloxx Pharmaceuticals, Inc.
Aug 12, 2026, 05:59 ET Apotex Announces First Quarter 2027 Results
provisions of the Company's share-based compensation in connection with the IPO.R&D expenses were $39 million, up $1 million compared to prior year. R&D spend represented 5% of net sales compared to 3% in prior year. The higher research and development expenses as
More news about: Apotex Health Corp.
Aug 12, 2026, 05:45 ET Odine and OdineLabs File Two Patent Applications Focused on Enterprise AI Technologies
integration, and AI-powered product innovation, has filed two patent applications together with its subsidiary OdineLabs, further strengthening its R&D efforts in artificial intelligence and next-generation software technologies. The applications cover technologies designed to enable AI agents to understand
More news about: Odine
Aug 12, 2026, 05:25 ET Beyang Closes Oversubscribed $30 Million Series A Financing
China, Aug. 12, 2026 /PRNewswire/ -- Beyang Therapeutics Co., Ltd. ("Beyang"), an AI-driven innovative drug R&D company dedicated to building a "DreamWorks" for innovative drug discovery, today announced the successful closing of an oversubscribed Series A financing
More news about: Beyang Therapeutics Co., Ltd.
Aug 12, 2026, 04:57 ET Minesto adapts organization to strengthen customer service offering
https://news.cision.com/minesto-ab/r/minesto-adapts-organization-to-strengthen-customer-service-offering,c4382428The following files are available for download:
More news about: Minesto AB
Aug 12, 2026, 04:53 ET Minesto adapts organization to strengthen customer service offering
https://news.cision.com/minesto-ab/r/minesto-adapts-organization-to-strengthen-customer-service-offering,c4382428The following files are available for download:
More news about: Minesto AB
Aug 12, 2026, 04:49 ET Công ty công nghệ sinh học Hàn Quốc K-Medichem mở rộng phạm vi tiếp cận thị trường toàn cầu với dòng sản phẩm chăm sóc da PDRN Derma tại Việt Nam, Indonesia và các thị trường khác
Được phát triển dựa trên công nghệ vật liệu sinh học tiên tiến và hoạt động nghiên cứu và phát triển (R&D) tại các trường đại học, DAYNICS hướng tới khôi phục trạng thái khỏe mạnh vốn có của làn da. Vượt ra ngoài việc dưỡng ẩm cơ bản, thương hiệu cung cấp
More news about: K-Medichem Co., Ltd.
Aug 12, 2026, 04:25 ET AMGEN TO OPEN NEW SCIENCE & INNOVATION CENTER IN GENOME VALLEY, HYDERABAD
efficiency."This new center reflects Amgen's commitment to advancing scientific excellence, and India will be an important part of our global R&D network," said Som Chattopadhyay, senior vice president of Global Business Solutions and national executive at Amgen. "By expanding Amgen's global
More news about: Amgen
Aug 12, 2026, 03:57 ET innoscripta SE: Successful US Market Entry - Clusterix Addresses New IRS Documentation Requirements under Form 6765
requirements under Form 6765, Section G, significantly increase the need for structured R&D documentation among US companiesUS is the world's largest R&D market: companies invested more than EUR 570 billion in R&D in 2025TUTZING, Germany,
More news about: innoscripta SE
Aug 12, 2026, 03:26 ET Boliden's mining concession for Laver maintained as appeals rejected
https://news.cision.com/boliden/r/boliden-s-mining-concession-for-laver-maintained-as-appeals-rejected,c4382416The following files are available for download:
More news about: Boliden
Aug 12, 2026, 03:05 ET हाई-पॉवर एप्लीकेशनों में थर्मल अवरोध को दूर करने के लिए Para Light ने ThermaFlat™ SiC MOSFETs लॉन्च किए
t-sic-mosfet-%e7%b3%bb%e5%88%97/ उच्च-विकास वाली विद्युत एप्लीकेशनों को गति प्रदान करनाThermaFlat™ रेंज पावर सिस्टमों के R&D इंजीनियरों को सिस्टम डिज़ाइन को सुव्यवस्थित करने में सक्षम बनाने के साथ-साथ AI डेटा सेंटर और सर्वर पॉवर सप्लाई, BBU और UPS सिस्टम, EV चार्जिंग स्टेशनों,
More news about: Para Light Electronics
Aug 12, 2026, 03:00 ET BASF Agricultural Solutions invests in new Climate Center at its headquarters to strengthen research capabilities
working with partners and experts to integrate sustainability criteria into all business decisions. With €990 million in 2025, we invest in a strong R&D pipeline, and our solutions are purpose-designed for different crop systems. Connecting seeds and traits, crop protection products, digital tools and
More news about: BASF Agricultural Solutions
Aug 12, 2026, 03:00 ET BASF Agricultural Solutions invests in new Climate Center at its headquarters to strengthen research capabilities
working with partners and experts to integrate sustainability criteria into all business decisions. With €990 million in 2025, we invest in a strong R&D pipeline, and our solutions are purpose-designed for different crop systems. Connecting seeds and traits, crop protection products, digital tools and
More news about: BASF Agricultural Solutions
Aug 12, 2026, 02:39 ET Skanska signs additional contract for medical office building in Durham, NC, USA, for USD 68M, about SEK 630M
https://news.cision.com/skanska/r/skanska-signs-additional-contract-for-medical-office-building-in-durham--nc--usa--for-usd-68m--about,c4382264The following files are available for download:
More news about: Skanska
Aug 12, 2026, 02:39 ET Strauss Group Reports Q2 & H1-2026 Financial Results:¹ Solid operating income growth to NIS 363 million, up 42%; Net profit doubled to NIS 195 million
Q2-2026 revenues of NIS 945 million, down 15.0% or 8.2% on a LFL basis, driven by lower selling prices partially offset by volume growth in R&G segment. Q2-2026 EBIT of approx. NIS 110 million, up ~25.0% (EBIT margin of 11.6%).H1-2026 revenues of NIS 1,856, down 12.4% or 7.1% on a
More news about: Strauss Group Ltd.
Aug 12, 2026, 02:36 ET Metacon publishes interim report for Q2 2026
https://news.cision.com/metacon-ab/r/metacon-publishes-interim-report-for-q2-2026,c4382224The following files are available for download:
More news about: Metacon AB
Aug 12, 2026, 02:26 ET PPWR - a new Phase for the European Packaging Market
circumstances, as well as navigate the new regulation. This provides both flexibility and reassurance for our customers," says Tomasz Doweyko, Manager R&D Innovation & Strategy.Changes to producer responsibilityFrom August 12 this year, new definitions will also begin to apply,
More news about: Duni Group
Aug 12, 2026, 02:00 ET Zurich Group Germany Accelerates Digital Transformation with Move to Guidewire Cloud
P&C insurers.We are proud of our unparalleled implementation record, with 1,700+ successful projects supported by the industry's largest R&D team and SI partner ecosystem. Our marketplace represents the largest partner community in P&C, where customers can access hundreds of applications
More news about: Guidewire Software
Aug 12, 2026, 01:56 ET Skanska to build Public Works Operations Campus for City of Vancouver, WA, USA, for USD 64M, about SEK 600M
https://news.cision.com/skanska/r/skanska-to-build-public-works-operations-campus-for-city-of-vancouver--wa--usa--for-usd-64m--about-s,c4382261The following files are available for download:
More news about: Skanska